{"id":"https://openalex.org/W1970809579","doi":"https://doi.org/10.1200/jco.2008.21.1763","title":"Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study","display_name":"Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study","publication_year":2009,"publication_date":"2009-10-27","ids":{"openalex":"https://openalex.org/W1970809579","doi":"https://doi.org/10.1200/jco.2008.21.1763","mag":"1970809579","pmid":"https://pubmed.ncbi.nlm.nih.gov/19858400"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.21.1763","doi":"https://doi.org/10.1200/jco.2008.21.1763","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.21.1763","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073989429","display_name":"Richard S. Finn","orcid":"https://orcid.org/0000-0003-2494-2126","observed_orcids":["https://orcid.org/0000-0003-2494-2126"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Richard S. Finn","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015668076","display_name":"Robert Gagnon","orcid":"https://orcid.org/0009-0000-5090-4866","observed_orcids":["https://orcid.org/0009-0000-5090-4866"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Robert Gagnon","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105140867","display_name":"Angelo Di Leo","orcid":"https://orcid.org/0000-0002-3665-9056","observed_orcids":["https://orcid.org/0000-0002-3665-9056"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Angelo Di Leo","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058453547","display_name":"Michael F. Press","orcid":"https://orcid.org/0000-0003-3400-6614","observed_orcids":["https://orcid.org/0000-0003-3400-6614"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Michael F. Press","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026406867","display_name":"Michael C. Arbushites","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Michael Arbushites","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048598383","display_name":"Maria T. Koehler","orcid":"https://orcid.org/0000-0002-4477-9621","observed_orcids":["https://orcid.org/0000-0002-4477-9621"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Maria Koehler","raw_affiliation_strings":["From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I161318765","https://openalex.org/I4210166882"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4951,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.92639053,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"27","issue":"33","first_page":"5552","last_page":"5558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-extracellular-domain","display_name":"HER2 extracellular domain","score":0.9959999918937683},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.5860000252723694},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8190000057220459},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9160000085830688},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7760000228881836},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9229999780654907},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7919999957084656},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.9655429124832153},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8852428197860718},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7548047304153442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7079996466636658},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6777158975601196},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6365336179733276},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6189478039741516},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.606961727142334},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5601741671562195},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4632362723350525},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.33804064989089966},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.27201342582702637},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2124098539352417},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077341","descriptor_name":"Lapatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017404","descriptor_name":"In Situ Hybridization, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2008.21.1763","doi":"https://doi.org/10.1200/jco.2008.21.1763","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.21.1763","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:19858400","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19858400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W53330856","https://openalex.org/W176192392","https://openalex.org/W1491740602","https://openalex.org/W1574463874","https://openalex.org/W1812955231","https://openalex.org/W1837870834","https://openalex.org/W1966823692","https://openalex.org/W1976090068","https://openalex.org/W1992592163","https://openalex.org/W1999461982","https://openalex.org/W1999946604","https://openalex.org/W2001627828","https://openalex.org/W2003792276","https://openalex.org/W2012784647","https://openalex.org/W2021019188","https://openalex.org/W2033779255","https://openalex.org/W2035484878","https://openalex.org/W2069724886","https://openalex.org/W2095156669","https://openalex.org/W2110444464","https://openalex.org/W2117305280","https://openalex.org/W2122812256","https://openalex.org/W2130074283","https://openalex.org/W2137399990","https://openalex.org/W2139248078","https://openalex.org/W2141217952","https://openalex.org/W2141393790","https://openalex.org/W2146406055","https://openalex.org/W2148689234","https://openalex.org/W2152494192","https://openalex.org/W2153130468","https://openalex.org/W2168106779","https://openalex.org/W2172265576","https://openalex.org/W2199607744","https://openalex.org/W2318605753","https://openalex.org/W2397597031","https://openalex.org/W3009187589","https://openalex.org/W3089528479","https://openalex.org/W3149591292","https://openalex.org/W4252112751"],"related_works":["https://openalex.org/W2125279632","https://openalex.org/W2589711376","https://openalex.org/W2562708962","https://openalex.org/W2538236034","https://openalex.org/W2244097286","https://openalex.org/W1992592163","https://openalex.org/W2273566413","https://openalex.org/W44945553","https://openalex.org/W1558802090","https://openalex.org/W2790147619"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"HER2":[2,32,47,90,143,249,274],"extracellular":[3],"domain":[4],"(ECD)":[5],"is":[6,27,276],"enzymatically":[7],"cleaved":[8],"from":[9,206,216],"the":[10,41],"cell":[11],"membrane.":[12],"Shed":[13],"ECD":[14,48,95,134,193,204,229,263,275],"in":[15,49,59,103,256,262],"serum":[16],"has":[17],"been":[18],"studied":[19],"as":[20],"both":[21],"prognostic":[22,42],"and":[23,33,43,114,127],"predictive":[24,44],"markers.":[25],"Lapatinib":[26],"a":[28,50,223,235],"dual":[29],"inhibitor":[30],"of":[31,46,53,246,270],"epidermal":[34],"growth":[35],"factor":[36],"receptor":[37],"kinases.":[38],"We":[39],"examined":[40],"role":[45],"randomized":[51],"trial":[52],"paclitaxel":[54,85,164,168],"with":[55,61,74,86,158,212,222,258,266],"placebo":[56,87,166],"or":[57,63,88],"lapatinib":[58,162,254],"women":[60],"HER2-negative":[62,151,259],"-unknown":[64],"breast":[65,78],"cancer.":[66],"PATIENTS":[67],"AND":[68],"METHODS:":[69],"Patients":[70],"(n":[71],"=":[72,110,179,191],"579)":[73],"newly":[75],"diagnosed":[76],"metastatic":[77],"cancer":[79],"(MBC)":[80],"were":[81,120,241],"randomly":[82],"assigned":[83],"to":[84,122,176,188,196,208,218,243,283],"lapatinib.":[89,247,284],"status":[91,145,264],"was":[92,96,155,202,210,220],"determined":[93],"centrally.":[94],"centrally":[97],"measured":[98],"by":[99],"enzyme":[100],"linked":[101],"immunoassay":[102],"available":[104],"samples":[105],"at":[106],"baseline":[107,133],"(b;":[108],"n":[109],"472),":[111],"week":[112],"9,":[113],"every":[115],"12":[116],"weeks":[117],"thereafter.":[118],"Results":[119],"correlated":[121,157],"overall":[123],"response":[124],"rate":[125],"(ORR)":[126],"progression-free":[128],"survival":[129],"(PFS).":[130],"RESULTS:":[131],"Elevated":[132],"(bECD)":[135],"levels":[136,194],"(>or=":[137],"16":[138],"ng/mL)":[139],"did":[140],"not":[141,156,252,277],"predict":[142,253],"tumor":[144],"(sensitivity,":[146],"62%;":[147],"specificity,":[148],"75%).":[149],"In":[150],"tumors,":[152],"elevated":[153,237],"bECD":[154,201,250],"improved":[159],"efficacy":[160],"for":[161,280],"plus":[163,167],"versus":[165],"(ORR:":[169],"odds":[170],"ratio,":[171,183],"1.6;":[172],"95%":[173,185],"CI,":[174,186],"0.1":[175],"3.8;":[177],"P":[178,190],".365;":[180],"PFS:":[181],"hazard":[182],"0.94;":[184],"0.60":[187],"1.47;":[189],".797).":[192],"tended":[195],"decrease":[197],"over":[198],"time":[199],"when":[200],"elevated.":[203],"conversion":[205],"low":[207,219,228],"high":[209,217],"associated":[211,221],"worse":[213],"PFS.":[214,225],"Converting":[215],"better":[224,232],"A":[226],"consistently":[227,236],"level":[230],"had":[231],"PFS":[233],"than":[234],"ECD.":[238],"All":[239],"associations":[240],"found":[242],"be":[244],"independent":[245],"CONCLUSION:":[248],"does":[251],"benefit":[255,282],"patients":[257],"MBC.":[260],"Changes":[261],"correlates":[265],"patient":[267],"outcome":[268],"regardless":[269],"treatment":[271],"given.":[272],"Measuring":[273],"currently":[278],"recommended":[279],"predicting":[281]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}